Medtronic PulseSelect system shows 100% acute success rate in AFib registry study

MDT•2026-10-22

Medtronic said its REAL PULSE registry showed a 100% acute success rate for the PulseSelect ablation system in atrial fibrillation patients.

1. Registry results

Medtronic announced real-world registry results for its Sphere-9 catheter and PulseSelect ablation system, presented at APHRS 2026. The REAL PULSE registry showed 100% acute success with PulseSelect and few major complications.

Medtronic PulseSelect system shows 100% acute success rate in AFib registry study

1. Registry results

Related News

Danaher target price raised to $250 from $240 by Deutsche Bank

Garanti BBVA secures EUR 400 million in financing under DPR programme

NuScale Power target price cut to $8 from $10 by Truist Securities

Alpha Compute joins Confidential Computing Consortium as premier member

Las Vegas Sands: Deutsche Bank cuts target price to $51 from $56